Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy [Phase 3]
A Phase 3 trial evaluating boceprevir-based therapy to rescue patients with chronic hepatitis C genotype 1 coinfected with hepatitis B who a…
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects [Phase 1]
Phase 1 safety, tolerability and pharmacokinetic study of Yimitasvir in healthy adult subjects has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C [NA]
Completed trial evaluating safety and efficacy of generic sofosbuvir with ribavirin for treatment-naive genotype 2 chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2018-03-01Clinical Trial Update: An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis C
This clinical trial update documents the completed observational study evaluating Pegasys in dual- or triple-therapy regimens for chronic he…
-
CLINICAL_TRIALS trial_result · 2018-02-22Clinical Trial Update: Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501 [Phase 2]
Phase 2 trial evaluating E5501 for hepatitis C virus–related thrombocytopenia has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-02-20Clinical Trial Update: Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection [Phase 3]
Phase 3 trial update on sofobuvir plus ribavirin in adults with chronic hepatitis C shows efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: 12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF [Phase 2]
Phase 2 trial comparing 12 weeks of ledipasvir/sofosbuvir with weight-based ribavirin to 24 weeks of ledipasvir/sofosbuvir in patients with …
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection [Phase 3]
A Phase 3 trial assessing safety and efficacy of the fixed-dose combination ledipasvir/sofosbuvir in adults with chronic hepatitis C and hep…
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC China II [Phase 2]
Phase 2 study evaluating the efficacy and safety of a 12-week triple therapy consisting of danoprevir/ritonavir plus pegylated interferon al…
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C [Phase 2]
Phase 2 trial update evaluating safety and efficacy of KW-136 with Sofosbuvir for chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis Patients [Phase 2]
Phase 2 trial update describing efficacy and safety of Qurevo Plus Ribavirin therapy for chronic hepatitis C in haemodialysis patients, with…
-
CLINICAL_TRIALS trial_result · 2018-01-12Clinical Trial Update: 3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study [Phase 3]
A Phase 3 follow-up trial investigating viral activity in chronic hepatitis C patients who previously failed feeder DEB025/Alisporivir; the …
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Ribavirin, Its Dosing Regime [Phase 4]
A Phase 4 clinical trial update on ribavirin dosing regime for Hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-27Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection [Phase 3]
Phase 3 trial evaluating safety and efficacy of a single-dose combination of Dactavira in Egyptian adults with chronic genotype 4 hepatitis …
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011) [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of grazoprevir and uprifosbuvir with either elbasvir or ruzasvir in chronic Hepatitis C g…
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C [Phase 2]
A Phase 2a dose-ranging study assessing VX-135 with ribavirin in treatment-naïve chronic hepatitis C patients has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-14Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection [Phase 3]
Phase 3 trial evaluating Ledipasvir/Sofosbuvir with or without Ribavirin in Egyptian adults with chronic genotype 4 HCV; results posted afte…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa [Phase 2]
A Phase 2 trial in West and Central Africa evaluated interferon-free sofosbuvir plus ribavirin for genotype 2 and sofosbuvir/ledipasvir for …
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy [Phase 3]
Phase 3 trial update evaluating safety and efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in adults with chronic hepatitis C who previously…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults [Phase 3]
Phase 3 trial of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in treatment-naïve adults with Hepatitis C Genotype 1b completed; results p…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma [Phase 3]
A Phase 3 study evaluating an all-oral regimen of ombitasvir/paritaprevir/ritonavir with or without dasabuvir and with or without ribavirin …
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects [Phase 2]
Phase 2 trial evaluating the antifibrotic agent GI262570 in patients with chronic hepatitis C and liver cirrhosis has completed, with result…
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects [Phase 2]
Phase 2 study evaluating safety, antiviral activity, and pharmacokinetics of GSK2336805 in combination with peginterferon and ribavirin in c…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients [Phase 4]
Phase 4 trial evaluating generic Velpatasvir/sofosbuvir with or without ribavirin in HIV/HCV coinfected patients; the study status is comple…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection [Phase 2]
Phase 2 trial assessing safety and efficacy of voxilaprevir with sofosbuvir/velpatasvir fixed-dose combination for adults with chronic genot…